Zymeworks (ZYME) Tops Q4 EPS by 22c
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Join SI Premium – FREE
Zymeworks (NYSE: ZYME) reported Q4 EPS of ($0.95), $0.22 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $19.87 million versus the consensus estimate of $9.13 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Nike (NKE) PT Lowered to $55 at BTIG
- Barclays Downgrades Brown Forman (BF-B) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
